Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Pharmaceutical Intermediates Synthesis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN100385007C details a microbial method for (R)-mandelic acid using Brevibacterium flavum, offering high optical purity and scalable biocatalysis for pharma intermediates.
Patent CN111229311B reveals a green synthesis method for 2-amino-3-cyano-4H-pyran compounds using KIT-6 supported ionic liquids, offering high yields and recyclability for pharmaceutical supply chains.
Advanced synthesis method for Rivaroxaban related substance triamine ensuring high purity and supply chain stability for pharmaceutical manufacturers globally.
Patent CN101100428A details a green boric acid-catalyzed route for high-purity chiral diethyl tartrate, offering cost reduction and zero-discharge manufacturing for pharma intermediates.
Novel bromination process for 6-bromo-2-chloro-8-cyclopentyl-5-methyl-pyrido[2,3-d]pyrimidin-7(8H)-one ensures high yield and low impurities for reliable supply chain.
Patent CN103145626B reveals a green synthesis route for key pharmaceutical intermediates, offering significant cost reduction and supply chain reliability for global buyers.
Patent CN115385835A discloses a green photocatalytic method for selenoester synthesis. Achieve high purity and cost reduction in fine chemical manufacturing with scalable room-temperature processes.
Novel hydrogenation route for dibenzyl ethylenediamine acetate. High purity >99%, low cost, scalable pharma intermediate manufacturing.
Patent CN113444041A details a mild, blue LED-driven route to quinolines. This metal-free process offers significant cost reduction and supply chain reliability for pharmaceutical intermediate manufacturing.
Patent CN110508323B details a water-phase Henry reaction using a recyclable thermosensitive chiral copper catalyst, offering high enantioselectivity and simplified downstream processing for pharmaceutical intermediates.
Novel three-step synthesis patent CN103694287A offers enhanced yield and purity. Reliable supply chain for pharmaceutical intermediates with significant cost reduction potential.
Novel binaphthyl-based phase transfer catalyst offering high enantioselectivity up to 98% ee. Ideal for pharmaceutical intermediates manufacturing with scalable processes.
Patent CN111718363B details a novel hydroboration method using stable azacarbene borane. Discover cost-effective synthesis for high-purity pharmaceutical intermediates.
Discover the atom-economical preparation of aryl eneyne compounds using Rh-catalyzed cross-hydroalkynylation. Enhance supply chain reliability and reduce manufacturing costs.
Patent CN103772229A details a green Cu2O-catalyzed oxidative amidation route. This method offers significant cost reduction and supply chain reliability for pharmaceutical intermediate manufacturing.
Patent CN113444004A details a cost-effective synthesis of 3,5-dibromo-o-aminobenzaldehyde from nitro waste, offering high-purity Ambroxol intermediates.
Discover CN114341098B patent technology for high-purity Coriolis Lactone synthesis. Enhance supply chain reliability and reduce manufacturing costs with our expert CDMO solutions.
Patent CN113045479B details a green FeCl3-catalyzed route for 3-hydroxyisoindol-1-ones, offering cost-effective API intermediate manufacturing solutions.
Patent CN110143875B reveals a high-yield route for Vitamin A intermediates, offering significant cost reduction and supply chain reliability for global manufacturers.
Novel styrene-based route for Loxoprofen intermediate. High purity, cost-effective, scalable manufacturing solution for global pharma supply chains.